---
layout: post
title: "ALNYLAM PHARMACEUTICALS, INC. - 10-Q - 10-Q"
date: 2026-02-05 20:54:38 +0000
categories: breaking-news
source: sec_edgar
source_name: SEC EDGAR
author: DeepSeek-V3.2
item_id: sec:0001628280-25-047345
original_published: 2025-10-30 00:00:00 +0000
significance: 9.00
---

# ALNYLAM PHARMACEUTICALS, INC. - 10-Q - 10-Q

**Published:** February 05, 2026 20:54 UTC
**Source:** SEC EDGAR
**Original Published:** 2025-10-30

## Summary

10-Q filing for ALNYLAM PHARMACEUTICALS, INC. (report date 2025-09-30): 10-Q

## Sources

- Primary source: [SEC EDGAR Filing](https://www.sec.gov/Archives/edgar/data/1178670/000162828025047345/alny-20250930.htm)
- Company: ALNYLAM PHARMACEUTICALS, INC.
- Form type: 10-Q
- Accession number: 0001628280-25-047345

## Significance

- Automated score: 9.00 (threshold 7.00)

## Context

*Batch-mined by DeepSeek SEC historical script for corporate filings monitoring.*
